Integration: Difference between revisions
From BurnZero
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
'''Integration is the [[Neuroplasticity|neuroplastic]] period that proceeds the [[Psychedelics|psychedelic]] experience, it is seen as a closing window of opportunity to integrate new thought patterns into the ''software'' of the brain.''' Better clinical outcomes can be achieved by augmenting this time using nature exposure<ref>'''Cross-sectional associations of different types of nature exposure with psychotropic, antihypertensive and asthma medication.''' Occupational and Environmental Medicine Turunen AW, Halonen J, Korpela K, et alPublished Online First: 16 January 2023. doi: 10.1136/oemed-2022-108491</ref> and [[Guided Psychedelic Therapy|guided psychedelic therapy]]. | '''Integration is the [[Neuroplasticity|neuroplastic]] period that proceeds the [[Psychedelics|psychedelic]] experience, it is seen as a closing window of opportunity to integrate new thought patterns into the ''software'' of the brain.''' Better clinical outcomes can be achieved by augmenting this time using nature exposure<ref>'''Cross-sectional associations of different types of nature exposure with psychotropic, antihypertensive and asthma medication.''' Occupational and Environmental Medicine Turunen AW, Halonen J, Korpela K, et alPublished Online First: 16 January 2023. doi: 10.1136/oemed-2022-108491 Accessed on 18 January 2023 via: https://oem.bmj.com/content/early/2023/01/05/oemed-2022-108491</ref> and [[Guided Psychedelic Therapy|guided psychedelic therapy]]. | ||
'''References''' | |||
Revision as of 23:19, 17 January 2023
Integration is the neuroplastic period that proceeds the psychedelic experience, it is seen as a closing window of opportunity to integrate new thought patterns into the software of the brain. Better clinical outcomes can be achieved by augmenting this time using nature exposure[1] and guided psychedelic therapy.
References
- ↑ Cross-sectional associations of different types of nature exposure with psychotropic, antihypertensive and asthma medication. Occupational and Environmental Medicine Turunen AW, Halonen J, Korpela K, et alPublished Online First: 16 January 2023. doi: 10.1136/oemed-2022-108491 Accessed on 18 January 2023 via: https://oem.bmj.com/content/early/2023/01/05/oemed-2022-108491